Abstract
CRISP (Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients) is a non-interventional, prospective, multi-center clinical research platform whose aim is to understand current treatment reality of patients with lung cancer in Germany. Here we present data of patients diagnosed with early-stage NSCLC (IIIB/C only if treated with curative intent), including first outcome data in routine-care.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
